The chronic subcutaneous administration of Ex-4 attenuates the peripheral symptoms of type 2 diabetes in rats, including hyperglycemia and IR, and enhances the levels of brain cortical GLP-1 and insulin-like growth factor (IGF)-1 and their downstream signaling pathways
By supporting mitochondrial function, NAD+ therapy may help improve stamina, mental clarity, and metabolic efficiency
Kalemi ine ucu yukarya bakacak ekilde tutun
Plsson-McDermott EM, ONeill LAJ
A treatment that works well for one person may not work as well for another
The article notes that patients new to GLP-1 medications often show a stronger initial response, and that tachyphylaxis, a reduced response with continued exposure, may develop over months